Breaking News Instant updates and real-time market news.

GNBT

Generex

$0.00

(0.00%)

09:12
10/15/19
10/15
09:12
10/15/19
09:12

Generex announces merger for public trading of NuGenerex Immuno-Oncology

Generex Biotechnology announced a merger transaction with a public company that is DTC eligible and current with its SEC filings to serve as a vehicle for the quotation of the common stock of its subsidiary NuGenerex Immuno-Oncology as an independent, publicly traded company. Generex is in the process of finalizing its annual report on Form 10-K, which will be filed in the coming days. The Form 10-K will include the audited financial statements for the legal documentation and Super Form 8-K filing for the merger of NGIO with the public vehicle. We expect that NuGenerex Immuno-Oncology will be quoted on a public exchange by the end of November, and the 1:4 shareholder dividend that was paid to Generex shareholders in February 2019 will be converted into public shares shortly thereafter. Generex has positioned its wholly-owned cancer subsidiary NuGenerex Immuno-Oncology to be merged with the public company, thereby completing the company's go-public strategy to realize the value of the Ii-Key technology and AE37 immunotherapeutic vaccine program. NGIO is currently enrolling a Phase II trial to establish the recommended biologic dose for AE37 Peptide Vaccine in combination with Keytruda that will enhance the tumor-specific immune response and demonstrate efficacy in patients with advanced triple-negative breast cancer; the trial is currently screening and enrolling patients at multiple clinical research sites.

  • 15

    Oct

  • 25

    Oct

GNBT Generex
$0.00

(0.00%)

06/26/19
06/26/19
NO CHANGE

Generex's Olaregen receives APMA 'seal of approval' for Excellagen Matrix
Generex Biotechnology announced that their subsidiary, Olaregen Therapeutix, Inc., received the prestigious "Seal of Approval" from the American Podiatric Medical Association for their Cellular Tissue Product, Excellagen Wound Conforming Matrix. Founded in 1912, the APMA is the leading resource for foot and ankle health information. Currently, the organization represents a vast majority of the estimated 18,000 podiatrists in the U.S. The APMA Seal of Approval/Acceptance Program evaluates the use of therapeutic agents and their adjunct and regulated medical devices. The seal is granted to a product after the Podiatric Seals Committee, a standing committee of the American Podiatric Medical Association, evaluates and determines whether the product allows normal foot function and promotes quality foot health. Additionally, evidence of usefulness and safety must be established, either by an appropriately recognized laboratory or clinical investigation, or by the products meeting certain physical standards. A detailed review is conducted by each committee member on every product. The committee then sends its recommendation to the APMA Board of Trustees, which has the authorization to either accept or reject the recommendation.

TODAY'S FREE FLY STORIES

13:06
11/15/19
11/15
13:06
11/15/19
13:06
General news
Baker-Hughes Rig Count N. Amer. data reported »

Week of 11/15…

USO

United States Oil Fund

$12.11

0.2 (1.68%)

, BKR

Baker Hughes

$22.73

0.85 (3.88%)

13:03
11/15/19
11/15
13:03
11/15/19
13:03
General news
Baker Hughes reports U.S. rig count down 11 to 806 rigs »

Baker Hughes reports that…

USO

United States Oil Fund

$12.11

0.2 (1.68%)

BKR

Baker Hughes

$22.73

0.85 (3.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTRA

Contura Energy

$8.73

-0.65 (-6.93%)

13:01
11/15/19
11/15
13:01
11/15/19
13:01
Hot Stocks
Contura Energy announces partial idling of Cumberland mine »

Contura Energy announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLDR

Cloudera

$8.79

0.25 (2.93%)

12:55
11/15/19
11/15
12:55
11/15/19
12:55
Options
Cloudera put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 09

    Dec

RHHBY

Roche

$0.00

(0.00%)

12:52
11/15/19
11/15
12:52
11/15/19
12:52
Hot Stocks
Roche to acquire Promedior in up to $1.4B deal »

Earlier, Promedior…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

12:50
11/15/19
11/15
12:50
11/15/19
12:50
Hot Stocks
Breaking Hot Stocks news story  »

TKK Symphony Acquisition…

CMCSK

Comcast

$0.00

(0.00%)

, CMCSA

Comcast

$44.58

-0.89 (-1.96%)

12:49
11/15/19
11/15
12:49
11/15/19
12:49
Hot Stocks
Hulu + Live TV price to increase to $54.99 per month from $44.99 per month »

Hulu announced that it is…

CMCSK

Comcast

$0.00

(0.00%)

CMCSA

Comcast

$44.58

-0.89 (-1.96%)

DIS

Disney

$145.45

-1.74 (-1.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

12:45
11/15/19
11/15
12:45
11/15/19
12:45
General news
Breaking General news story  »

Week of 11/15…

BA

Boeing

$371.03

3.73 (1.02%)

, UAL

United Airlines

$92.97

0.43 (0.46%)

12:41
11/15/19
11/15
12:41
11/15/19
12:41
Hot Stocks
United Airlines pulls 737 Max jets off schedule until March 4 »

United Airlines (UAL) is…

BA

Boeing

$371.03

3.73 (1.02%)

UAL

United Airlines

$92.97

0.43 (0.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APDN

Applied DNA Sciences

$4.50

-0.38 (-7.79%)

12:38
11/15/19
11/15
12:38
11/15/19
12:38
Hot Stocks
Empery Asset Management reports 7.17% passive stake in Applied DNA Sciences »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:35
11/15/19
11/15
12:35
11/15/19
12:35
Hot Stocks
Breaking Hot Stocks news story  »

TKK Symphony Acquisition…

TSLA

Tesla

$349.70

0.19 (0.05%)

, VWAGY

Volkswagen

$0.00

(0.00%)

12:25
11/15/19
11/15
12:25
11/15/19
12:25
Periodicals
VW CEO says company has no plans to cooperate with Tesla, Reuters reports »

Volkswagen (VWAGY) CEO…

TSLA

Tesla

$349.70

0.19 (0.05%)

VWAGY

Volkswagen

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TLRD

Tailored Brands

$5.17

0.03 (0.58%)

12:25
11/15/19
11/15
12:25
11/15/19
12:25
Options
Tailored Brands call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

NVDA

Nvidia

$206.25

-3.63 (-1.73%)

, AMZN

Amazon.com

$1,750.30

-4.41 (-0.25%)

12:23
11/15/19
11/15
12:23
11/15/19
12:23
On The Fly
Fly Intel: Wall Street's top stories at midday »

Stocks have been higher…

NVDA

Nvidia

$206.25

-3.63 (-1.73%)

AMZN

Amazon.com

$1,750.30

-4.41 (-0.25%)

MSFT

Microsoft

$149.59

1.53 (1.03%)

UAA

Under Armour

$17.82

0.69 (4.03%)

UA

Under Armour

$16.04

0.48 (3.08%)

AMRN

Amarin

$22.89

1.4 (6.51%)

RH

RH

$188.04

12.85 (7.33%)

BRK.A

Berkshire Hathaway

$329,640.00

545 (0.17%)

BRK.B

Berkshire Hathaway

$219.62

0.26 (0.12%)

FTCH

Farfetch

$9.69

2.2 (29.37%)

AMAT

Applied Materials

$62.33

5.44 (9.56%)

ACB

Aurora Cannabis

$3.00

-0.29 (-8.81%)

OXY

Occidental Petroleum

$38.90

1.14 (3.02%)

TORC

resTORbio

$1.16

-6.77 (-85.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 19

    Nov

  • 20

    Nov

  • 20

    Nov

  • 04

    Dec

  • 09

    Dec

  • 09

    Dec

  • 28

    Dec

  • 06

    Jan

TORC

resTORbio

$1.14

-6.79 (-85.62%)

12:21
11/15/19
11/15
12:21
11/15/19
12:21
Downgrade
resTORbio rating change  »

resTORbio downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WE

We Company

$0.00

(0.00%)

12:18
11/15/19
11/15
12:18
11/15/19
12:18
Periodicals
We Company facing SEC probe into possible rule breaches, Bloomberg says »

We Company's WeWork…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FCBP

First Choice Bank

$22.49

-0.01 (-0.04%)

12:17
11/15/19
11/15
12:17
11/15/19
12:17
Hot Stocks
First Choice Bancorp announces resignation of CFO Lynn Hopkins »

First Choice Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXP

American Express

$120.92

-0.03 (-0.02%)

12:17
11/15/19
11/15
12:17
11/15/19
12:17
Hot Stocks
AmEx reports October consumer card write-off rate 2.3% vs. 2.0% last month »

American Express reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
11/15/19
11/15
12:17
11/15/19
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
11/15/19
11/15
12:16
11/15/19
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMGN

Amgen

$219.62

1.07 (0.49%)

12:10
11/15/19
11/15
12:10
11/15/19
12:10
Hot Stocks
Amgen treatment of multiple myeloma granted FDA orphan designation »

Amgen's treatment of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

AXGT

Axovant

$4.71

-0.05 (-1.05%)

12:07
11/15/19
11/15
12:07
11/15/19
12:07
Hot Stocks
Axovant granted FDA orphan designation for treatment of GM1 gangliosidosis »

Axovant Sciences was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LYFT

Lyft

$43.75

1.85 (4.42%)

, FB

Facebook

$194.64

1.49 (0.77%)

12:05
11/15/19
11/15
12:05
11/15/19
12:05
Recommendations
Lyft, Facebook, Amazon.com, Netflix, Twitter, IAC analyst commentary  »

JPMorgan adds Lyft to…

LYFT

Lyft

$43.75

1.85 (4.42%)

FB

Facebook

$194.64

1.49 (0.77%)

AMZN

Amazon.com

$1,747.79

-6.92 (-0.39%)

NFLX

Netflix

$293.25

3.57 (1.23%)

TWTR

Twitter

$29.38

0.49 (1.70%)

IAC

IAC

$223.02

2.85 (1.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 19

    Nov

  • 19

    Nov

  • 19

    Nov

  • 20

    Nov

  • 21

    Nov

  • 09

    Dec

  • 10

    Dec

  • 06

    Feb

AUPH

Aurinia Pharmaceuticals

$5.37

0.23 (4.47%)

12:05
11/15/19
11/15
12:05
11/15/19
12:05
Options
Aurinia Pharmaceuticals call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:05
11/15/19
11/15
12:05
11/15/19
12:05
General news
Fed Q4 Nowcasts revised lower. »

Fed Q4 Nowcasts revised…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.